Status:
COMPLETED
Therapy and Outcome of Prolonged Veno-venous ECMO Therapy of Critically Ill ARDS Patients.
Lead Sponsor:
Goethe University
Conditions:
Extracorporeal Membrane Oxygenation Complication
Outcome, Fatal
Eligibility:
All Genders
18+ years
Brief Summary
In the context of the coronavirus (COVID-19) pandemic, healthcare systems worldwide faced an unprecedented shortage of severe ARDS. Critically affected patients were treated with veno-venous extracorp...
Eligibility Criteria
Inclusion
- veno-venous extracorporeal membrane oxygenation
Exclusion
- veno-arterial extracorporeal membrane oxygenation
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05338593
Start Date
May 1 2022
End Date
May 15 2023
Last Update
August 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Frankfurt
Frankfurt am Main, Hesse, Germany, 60590